NASDAQ:VRNA

Verona Pharma News Headlines

$6.31
-0.41 (-6.10 %)
(As of 05/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.30
$6.65
50-Day Range
$6.80
$9.09
52-Week Range
$3.70
$15.71
Volume43,202 shs
Average Volume113,912 shs
Market Capitalization$365.57 million
P/E RatioN/A
Dividend YieldN/A
Beta0.4

Headlines

Verona Pharma (NASDAQ VRNA) News Headlines Today

SourceHeadline
Verona Pharma plc Forecasted to Post Q1 2022 Earnings of ($0.40) Per Share (NASDAQ:VRNA)Verona Pharma plc Forecasted to Post Q1 2022 Earnings of ($0.40) Per Share (NASDAQ:VRNA)
americanbankingnews.com - May 5 at 4:38 AM
Verona Pharma (NASDAQ:VRNA) PT Lowered to $18.00Verona Pharma (NASDAQ:VRNA) PT Lowered to $18.00
americanbankingnews.com - May 3 at 12:09 PM
FY2025 EPS Estimates for Verona Pharma plc Boosted by Analyst (NASDAQ:VRNA)FY2025 EPS Estimates for Verona Pharma plc Boosted by Analyst (NASDAQ:VRNA)
americanbankingnews.com - May 3 at 4:52 AM
Brokers Set Expectations for Verona Pharma plcs Q1 2022 Earnings (NASDAQ:VRNA)Brokers Set Expectations for Verona Pharma plc's Q1 2022 Earnings (NASDAQ:VRNA)
americanbankingnews.com - May 3 at 4:18 AM
Verona Pharma Reports First Quarter 2021 Financial Results and Provides Corporate UpdateVerona Pharma Reports First Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - April 29 at 7:49 AM
Verona Pharma plc (NASDAQ:VRNA) Sees Large Growth in Short InterestVerona Pharma plc (NASDAQ:VRNA) Sees Large Growth in Short Interest
americanbankingnews.com - April 29 at 1:28 AM
Verona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary DiseaseVerona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary Disease
finance.yahoo.com - April 27 at 8:32 AM
 Analysts Anticipate Verona Pharma plc (NASDAQ:VRNA) Will Announce Earnings of -$0.45 Per Share Analysts Anticipate Verona Pharma plc (NASDAQ:VRNA) Will Announce Earnings of -$0.45 Per Share
americanbankingnews.com - April 24 at 8:12 AM
Zacks: Brokerages Anticipate Verona Pharma plc (NASDAQ:VRNA) to Announce -$0.45 Earnings Per ShareZacks: Brokerages Anticipate Verona Pharma plc (NASDAQ:VRNA) to Announce -$0.45 Earnings Per Share
americanbankingnews.com - April 24 at 8:12 AM
Verona Pharma Reports Results of Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19Verona Pharma Reports Results of Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
finance.yahoo.com - April 23 at 6:16 AM
Verona Pharma (VRNA) Set to Announce Earnings on ThursdayVerona Pharma (VRNA) Set to Announce Earnings on Thursday
americanbankingnews.com - April 22 at 4:06 AM
Revisiting Verona PharmaceuticalsRevisiting Verona Pharmaceuticals
seekingalpha.com - March 2 at 7:39 AM
Verona Pharma plc 2020 Q4 - Results - Earnings Call PresentationVerona Pharma plc 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 26 at 1:49 PM
Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate UpdateVerona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
markets.businessinsider.com - February 18 at 2:29 AM
Verona Pharmas pMDI Ensifentrine Shows Improved Lung Function In Mid-Stage COPD StudyVerona Pharma's pMDI Ensifentrine Shows Improved Lung Function In Mid-Stage COPD Study
msn.com - February 2 at 7:25 AM
CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPDCORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD
finance.yahoo.com - February 2 at 7:25 AM
Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
finance.yahoo.com - January 14 at 3:02 AM
Verona Pharma to Present at H.C. Wainwright Virtual BioConnect ConferenceVerona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
finance.yahoo.com - January 5 at 7:21 AM
Verona Pharma to Present at H.C. Wainwright Virtual BioConnect ConferenceVerona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
feeds.benzinga.com - January 5 at 2:32 AM
News for Verona Pharma PLC Registered ShsNews for Verona Pharma PLC Registered Shs
markets.businessinsider.com - December 24 at 9:51 AM
Is VRNA A Good Stock To Buy Now?Is VRNA A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 3:05 PM
25 Best U.S. Cities to Live With Asthma25 Best U.S. Cities to Live With Asthma
finance.yahoo.com - November 25 at 12:00 AM
Verona Pharma Secures up to $30 Million Debt Financing from Silicon Valley BankVerona Pharma Secures up to $30 Million Debt Financing from Silicon Valley Bank
finance.yahoo.com - November 23 at 9:30 AM
Verona Pharma EPS beats by $0.15Verona Pharma EPS beats by $0.15
seekingalpha.com - October 30 at 3:10 PM
Verona Pharma Plcto Host Earnings CallVerona Pharma Plcto Host Earnings Call
finance.yahoo.com - October 29 at 12:31 PM
Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020
finance.yahoo.com - October 29 at 7:31 AM
Verona COPD Trial, And Other News: The Good, Bad And Ugly Of BiopharmaVerona COPD Trial, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - October 27 at 7:42 AM
Verona Pharma plc (I9S1.SG)Verona Pharma plc (I9S1.SG)
in.finance.yahoo.com - October 11 at 5:07 PM
Verona Pharma plc Rings the Closing BellVerona Pharma plc Rings the Closing Bell
nasdaq.com - September 21 at 2:30 PM
Intended Delisting and Cancellation of Ordinary Shares from Trading on AIMIntended Delisting and Cancellation of Ordinary Shares from Trading on AIM
finance.yahoo.com - September 21 at 4:05 AM
Verona Pharma Announces Publication of Phase 2b COPD Symptom Data in the International Journal of Chronic Obstructive Pulmonary DiseaseVerona Pharma Announces Publication of Phase 2b COPD Symptom Data in the International Journal of Chronic Obstructive Pulmonary Disease
finance.yahoo.com - September 16 at 8:39 AM
Verona Pharma commences pMDI ensifentrine study in COVID-19 patients in the U.S.Verona Pharma commences pMDI ensifentrine study in COVID-19 patients in the U.S.
seekingalpha.com - September 8 at 10:32 AM
Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
finance.yahoo.com - September 8 at 5:32 AM
Verona Pharma plc (VRNA)Verona Pharma plc (VRNA)
in.finance.yahoo.com - August 14 at 2:17 PM
Verona Pharma plc (VRNA) CEO David Zaccardelli on Q2 2020 Results - Earnings Call TranscriptVerona Pharma plc (VRNA) CEO David Zaccardelli on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 14 at 2:17 PM
Verona Pharma plc: TR-1: Standard form for notification of major holdingsVerona Pharma plc: TR-1: Standard form for notification of major holdings
finance.yahoo.com - July 27 at 7:20 AM
Closing of Financing, Issued Share Capital and Total Voting RightsClosing of Financing, Issued Share Capital and Total Voting Rights
finance.yahoo.com - July 22 at 2:03 PM
Stock Alert: Verona Pharma Loses 14%Stock Alert: Verona Pharma Loses 14%
www.nasdaq.com - July 20 at 12:57 PM
Stock Alert: Verona Pharma Trading 85% HigherStock Alert: Verona Pharma Trading 85% Higher
markets.businessinsider.com - July 20 at 12:40 AM
Verona Pharma raises $200M financingVerona Pharma raises $200M financing
seekingalpha.com - July 17 at 12:00 PM
Verona Pharma Raises $200 Million in Oversubscribed Private Placement and SubscriptionVerona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
finance.yahoo.com - July 17 at 7:00 AM
Hedge Funds Are Crazy About Bassett Furniture Industries Inc. (BSET)Hedge Funds Are Crazy About Bassett Furniture Industries Inc. (BSET)
finance.yahoo.com - July 8 at 11:15 PM
VRNA Verona Pharma plc American Depositary ShareVRNA Verona Pharma plc American Depositary Share
www.nasdaq.com - May 15 at 7:02 PM
Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical ProgramVerona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical Program
finance.yahoo.com - May 14 at 4:08 AM
Verona Pharma down 30% on uncertainty with Phase 3 ensifentrine studyVerona Pharma down 30% on uncertainty with Phase 3 ensifentrine study
seekingalpha.com - May 2 at 9:16 AM
Verona Pharma plc (VRNA) CEO David Zaccardelli on Q1 2020 Results - Earnings Call TranscriptVerona Pharma plc (VRNA) CEO David Zaccardelli on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 1 at 11:14 PM
Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International ConferenceVerona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference
finance.yahoo.com - May 1 at 6:14 PM
Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020
finance.yahoo.com - April 30 at 6:02 AM
Verona Pharma to Announce Financial Results for the Three Months Ended March 31, 2020 and Provide Corporate UpdateVerona Pharma to Announce Financial Results for the Three Months Ended March 31, 2020 and Provide Corporate Update
finance.yahoo.com - April 23 at 7:09 AM
Will Verona Pharma Continue to Surge Higher?Will Verona Pharma Continue to Surge Higher?
finance.yahoo.com - April 17 at 2:00 PM
This page was last updated on 5/5/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.